Semiconductors
RGTI revenue surged 185% in Q2 FY2026 on Novera product sales, but net loss widened to $52.6 million due to higher R&D and a non-cash warrant charge.
Key risk: Early Stage and Roadmap Uncertainty
The company has a limited operating history and has previously failed to meet publicly announced milestones and changed its technology roadmap; there is no assurance future milestones will be achieved, which could materially impact commercialization.